Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled 99mTc-labeled carbon aerosol in COVID-19 pneumonia
NCT04724538Phase 2Completed
- Start
- Oct 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of technetium Tc-99m sodium pertechnetate in coronavirus disease 2019 (COVID-19), viral pneumonia. Started Oct 2020; status: completed.
02
Drugs
technetium Tc-99m sodium pertechnetate
03
Conditions
coronavirus disease 2019 (COVID-19)viral pneumonia
Beyond the preview
Go deeper on NCT04724538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724538.